hplc-verified ric-8a peptides (GenicBio BioTech Co Ltd)
Structured Review

Hplc Verified Ric 8a Peptides, supplied by GenicBio BioTech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hplc-verified ric-8a peptides/product/GenicBio BioTech Co Ltd
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A"
Article Title: The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A
Journal: eLife
doi: 10.7554/eLife.86151
Figure Legend Snippet: ( A ) Ribbon representation of NCS protein structures bound to their targets. NCS-1/D2R (PDB: 5AER, ), NCS-1/Grk1 (PDB: 5AFP, ), Frq1/Pik1 (PDB: 2JU0, ), KChIP1/Kv4.3 (PDB: 2I2R, ), Recoverin/RK25 (PDB: 2I94, ), Frq2 (PDB: 4BY4, ). The N and C-terminal pairs of EF-hands (EF-1–2 and EF-3–4) are shown in cyan and purple respectively. The C-terminal helix H10 is shown in pink and target proteins in yellow. Ca 2+ is shown as hot pink spheres. ( B ) Top: Cryo-EM structure of the rRic-8A/Gα i1 complex (PDB: 6UKT, ). Gα i1 is depicted in silver. Ric-8A ARM-HEAT repeats 1–8 in blue and repeat 9 in green and helices H10 (rH10) and H11 (rH11) in orange and gold respectively. The C-terminal coiled regions are shown in magenta. Phosphorylated residues S435 and T440 are depicted as spheres. Bottom: rRic-8A sequence from residue 400 to the end. Helices are squared following the same color code used above. Phosphorylation sites are indicated as red spheres. P1, P2, and P3 brackets indicate the boundaries of the synthesized Ric-8A peptides.
Techniques Used: Cryo-EM Sample Prep, Sequencing, Residue, Synthesized
Figure Legend Snippet: ( A ) Ribbon representation of the hNCS-1ΔH10/Ric-8A-P3 complex. Two views are displayed. The NCS-1 structure is shown in light purple, while Ric-8A-P3 is shown in light pink. The N- and C-termini are indicated. Ca 2+ , Na + , and Cl - ions are shown in hot pink, yellow, and cyan, respectively. R1 and R2 helices, and EF-hands 2, 3, and 4 are indicated. The orange square represents a zoomed view of the R1-R2 loop in stick mode, Cl - coordination and H-bonds are displayed as yellow and gray dashes, respectively. Residues participating in R1-R2 contacts are displayed in hot pink (triad 1: I407-T410-A415), magenta (F406-L418), and purple (triad 2: K408-Y409-N414). ( B ) rRic-8A sequence from 400 to 442 residues. The helix boundaries of Ric-8A sequence encompassing a9 and b9 in different structural contexts (NCS-1/Ric-8A-peptide [PDB: 8AHY], Ric-8A/Gα [PDB: 6UKT, ] and uncomplexed Ric-8A [PDB: 6NMG, ]) are indicated as pink boxes and labeled. Coiled regions are shown in pink. Disordered regions are shown in gray, while phosphorylated sites are shown as red spheres. The interacting residues shown in panel ( A ) are indicated with dots in the same color code as in A . ( C ) Electrostatic surface potential of rRic-8A-P3. NCS-1 is shown as yellow ribbons. Positive and negative potentials are represented in blue and red, respectively. On the right, the Ric-8A region that faces and contacts NCS-1 is shown with NCS-1 removed for proper visualization. ( D ) Representative co-immunoprecipitation assay in HEK293 cells transfected with full-length hNCS-1 and V5-tagged hRic-8A mutants. Mutations on NCS-1 and Ric-8A are indicated in blue and pink, respectively. The numbering of the rat Ric-8A sequence has been maintained for proper comparison with A and B. Quantifications of each lane from three independent experiments (mean ± SD) are shown on the right. Mean differences were analyzed by two-tailed, paired Student’s t-test, comparing with wild-type NCS-1 and Ric-8A. **p=0.01; *p=0.05. Figure 3—source data 1. Original WBs.
Techniques Used: Sequencing, Labeling, Co-Immunoprecipitation Assay, Transfection, Comparison, Two Tailed Test
Figure Legend Snippet: ( A ) Structure 1 showing the 2F o -F c electron density map (green) of Ric-8A-P2 (stick mode, pink). The molecular surface of NCS-1 is depicted. Squares represent magnifications of R1 and R2 regions. ( B ) Left: Superimposition of Structures 1 and 2. NCS-1 and Ric-8A peptide threads in blue and in pink tones, respectively. The gray arrow indicates the main differences found in Ric-8A peptide structures. ( C ) Temperature factor representation of Structure 2 (blue and red, high and low values, respectively) in two rotated views.
Techniques Used:
Figure Legend Snippet: ( A ) Ribbon representation of NCS-1. Helices are labeled and residues implicated in Ric-8A recognition are displayed as light purple sticks. ( B ) H-bonds (black dashes) between NCS-1 (gray) and Ric-8A (pink). Interacting residues are shown as pink sticks and light-purple sticks, respectively. Water molecules are displayed as red spheres. ( C ) H-bonds found in the R1-R2 loop. A rotated and zoomed view of that shown in B is depicted. ( D ) Ric-8A residues implicated in van der Waals interactions are displayed in sticks and labeled. Ric-8A is shown as pink ribbon and the molecular surface of NCS-1 is represented. Residues that were mutated to alanine to verify the protein-protein interaction (PPI) interface are indicated in purple in A–D.
Techniques Used: Labeling
Figure Legend Snippet: ( A ) Identification of Ca 2+ , Mg 2+ , and Na + ions in the hNCS-1ΔH10/Ric-8A-P3 complex (Structure 2, see ). Top: Electron density at EF-hands EF-2, -3 and -4. The 2F o -F c electron density map (contoured at 1.0σ) and the anomalous difference map (contoured at 6.0σ) are shown in green and blue, respectively. NCS-1 is shown in stick mode (light purple), Ca 2+ and Na + ions as hot pink and yellow spheres, respectively, and water molecules (w) as red spheres. Bottom: The Mg 2+ ion (green sphere) found in Structures 1 and 2 (see ). NCS-1 symmetry-related molecule is depicted in yellow. ( B ) The binding of Na + to hNCS-1 in solution. Representation of the normalized fluorescence emission (mean ± standard error of the mean [SEM]; n=3) of full-length hNCS-1 at increasing concentrations of NaCl or KCl. The curves are the least squares fitting of the experimental data to a 1:1 stoichiometry equilibrium. Na + and K + titrations are shown in blue and magenta, respectively. ( C ) Assembly of the NCS-1ΔH10/rRic-8A-452 complex in the presence of 200 mM Na + (blue) or K + (magenta). Size exclusion chromatograms indicating the elution of the assembled complexes ( C ). ( D ) Isothermal titration calorimetry (ITC) binding isotherm at 25°C for Ca 2+ to NCS-1 in 20 mM Tris pH 7.9 supplemented with 150 mM Na + (blue) or 150 mM K + (magenta). Solid lines show the best fits of the titration data in terms of a three-site sequential binding model using the thermodynamic parameters shown in . Θ is the fraction of sites available for each class of Ca 2+ sites. ( E ) The binding of full-length His-NCS-1 to Ric-8A-P3 peptide at increasing Ca 2+ concentrations. Representative biolayer interferometry (BLI) sensograms showing association and dissociation of Ric-8A-P3 over the time. Data are represented as the wavelength shift, △λ (nm), during the association and dissociation phases (s). Figure 4—source data 1. Raw chromatograms, nano-DSF and Bli data.
Techniques Used: Binding Assay, Fluorescence, Isothermal Titration Calorimetry, Titration
Figure Legend Snippet: ( A ) Nano-differential scanning fluorimetry (nano-DSF) curve of the His-NCS-1 sample used in the BLI assay. ( B ) Representative BLI sensogram of the binding of His-NCS-1 to the Ni-NTA biosensor and negative control showing that Ric-8A-P3 peptide does not bind to the biosensor in the absence of NCS-1. ( C ) BLI sensograms at increasing concentrations of Ric-8A-P3 peptide.
Techniques Used: Nano Differential Scanning Fluorimetry, Binding Assay, Negative Control
Figure Legend Snippet: ( A ) Co-IP protein-protein interaction assay of hNCS-1 and V5-tagged full-length hRic-8A wild-type (WT) (hRic-8A-WT) and a non-phosphorylatable mutant (Ric-8A-P-Mut; S436A, T441A) in HEK293 cells. ( B ) Anionic exchange chromatograms of casein kinase II (CK2)-treated samples eluted in a salt gradient. On the left, phosphorylated and unphosphorylated rRic-8A-452 prRic-8A-452 (orange) and urRic-8A-452 (green), respectively. On the right, CK2 treated (pink) or untreated (blue) NCS-1ΔH10/rRic-8A samples. Conductivity (mS/cm) is shown as gray lines. ( C ) Size exclusion chromatograms of the resulting samples after the assembly of NCS-1ΔH10 with unphosphorylated (green) and phosphorylated (orange) rRic-8A-452. C stands for assembled complex. Figure 5—source data 1. Original WBs and raw chromatogram data.
Techniques Used: Co-Immunoprecipitation Assay, Protein Protein Interaction Assay, Mutagenesis
Figure Legend Snippet: ( A ) The structure of the rRic-8A/G⍺ i1 complex (PDB: 6UKT, ). Electrostatic potential surface representation of ARM-HEAT domain (repeats 1–8). The repeat 9 is shown as ribbons. The Ric-8A region present in the NCS-1/Ric-8A-P crystal structure is shown in green and side chains of the corresponding residues in stick mode. Phosphorylated S435 and T440 are indicated. ( B ) Superposition of the structures of Ric-8A bound to G⍺ (magenta and green, PDB: 6UKT, ), uncomplexed rRic-8A (yellow, PDB: 6NMG, ), Ric-8A peptide (light purple) bound to hNCS-1. Ric-8A helix R2 of the complex with NCS-1 was superposed with helix b9 of uncomplexed Ric-8A. ( C ) Schematic representation of Ric-8A ARM/HEAT repeat domain (repeats 1–9 are indicated) explaining the detachment of 9 for NCS-1/Ric-8A assembly. The redistribution of charged (blue) and hydrophobic residues (green) in Ric-8A repeat 9 generates the platform for NCS-1 recognition. Repeats 1–8 have been colored in different gray tonalities since previous studies have shown global changes within the ARM-HEAT repeat domain of unphosphorylated Ric-8A compared to the phosphorylated version .
Techniques Used:
Figure Legend Snippet: ( A , B ) Superposition of NCS-1/Ric-8A-P (only Ric-8A is shown in pink ribbons) with other NCS-1 structures in complex with regulatory ligands, the protein-protein interaction (PPI) inhibitor FD-44 and the PPI stabilizer 3b . The molecular surface of NCS-1 is represented except the helix H10 (ribbon). FD-44 and 3b compounds are represented in stick mode and yellow arrows indicate their position. ( C ) Superposition of the structure of hNCS-1 (light purple) bound to Ric-8A-P (pink) with that of hNCS-1 (light blue; helix H10 in dark blue) bound to 3b regulator (cyan sticks). Yellow arrows indicate the NCS-1 regions that rearrange to accommodate Ric-8A. ( D ) Superposition of the hNCS-1/Ric-8A-P (light purple/pink) complex with that of the KChIP1/Kv4.3 (orange/green) complex (PDB: 2I2R (52)). N- and C-terminal end of the different polypeptide chains are indicated following the same color code.
Techniques Used:
Figure Legend Snippet: Step 1: At low Ca 2+ concentrations NCS-1 interacts with unphosphorylated Ric-8A (uRic-8A), at the plasma membrane. NCS-1 protects Ric-8A from phosphorylation or Gα subunit binding. Ric-8A ARM-HEAT repeat domain is labeled with a question mark since the structure in the context of the NCS-1 complex is unknown. Step 2: When Ca 2+ levels increase in the cytosol, NCS-1 binds Ca 2+ at EF-4 and the complex is disassembled. NCS-1 helix H10 inserts in the hydrophobic crevice (green) and would be ready for dopamine D2 receptor recognition. Inactive uRic-8A, free of NCS-1, repacks repeats 8 and 9 (helices a9 and b9 in light green) and S335 and T440 are phosphorylated (P) by casein kinase II (CK2) (Step 3). In this state, phosphorylated Ric-8A (pRic-8A) is now active, recognizes prefolded Gα subunit and allows GTP loading (Step 4).
Techniques Used: Membrane, Binding Assay, Labeling
Figure Legend Snippet:
Techniques Used: Recombinant, Plasmid Preparation, Residue, Construct, Mutagenesis, Software, Purification
